BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 17, 2011
View Archived Issues
Sanofi profiles pipeline highlights of third quarter 2011
Read More
Almirall and BioFocus enter collaboration
Read More
Eisai develops novel lanosterol synthase inhibitor for HCV
Read More
Preclinical profile of Merck & Co.'s HCV NS5A inhibitor MK-4882 described
Read More
Achillion Pharmaceuticals describes second-generation NS5A inhibitors
Read More
Gilead and Tibotec finalize agreement on single-tablet HIV regimen
Read More
EB-1020 as a new approach to treat ADHD
Read More
Favorable preclinical profile of C-21191 supports development for pain, spasticity
Read More
AVI BioPharma enters collaborations for two new exon-skipping drugs
Read More
Midatech obtains Swiss approval to test insulin-coated gold nanoparticles
Read More
Patient recruitment commences in phase I study of MK-1439 for HIV-1 infection
Read More
Researchers in India disclose novel NO-releasing prodrugs
Read More
UCB offers review of third quarter 2011
Read More
Phase I LG-631 gene therapy trial initiated for brain cancer
Read More
PharmacoFore presents new enzyme-cleavable amphetamine prodrugs
Read More
Prosidion researchers prepare novel GPR119 receptor agonists/DPP IV inhibitors
Read More
Array BioPharma patents new tyrosine-protein kinase inhibitors
Read More
Genzyme and Cystic Fibrosis Foundation enter collaboration for new cystic fibrosis drugs
Read More
Novel tyrosine-protein kinase inhibitors synthesized by MethylGene
Read More
Phase I MTN-013/IPM 026 safety trial for HIV enters subject screening stage
Read More
Profectus BioSciences receives additional grant from PATH Malaria Vaccine Initiative
Read More
PharmaGap starts animal efficacy study of GAP-107B8
Read More
BioSante Pharmaceuticals reports results from LibiGel pharmacokinetic study
Read More
Athersys regains rights to MultiStem cardiovascular program
Read More
Bristol-Myers Squib seeks approval of new indication for Taxol in Japan
Read More
InSite Vision starts phase III study of AzaSite Plus and DexaSite for blepharitis
Read More